BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21391912)

  • 1. Tissue-specific therapeutic targeting of p53 in cancer: one size does not fit all.
    Vlatković N; Crawford K; Rubbi CP; Boyd MT
    Curr Pharm Des; 2011; 17(6):618-30. PubMed ID: 21391912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [p53 as a molecular target for cancer therapy].
    Ishioka C; Osada M; Gamo M; Kanamaru R
    Gan To Kagaku Ryoho; 1997 Dec; 24(15):2207-12. PubMed ID: 9422063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53-targeted cancer pharmacotherapy: move towards small molecule compounds.
    Kim SH; Dass CR
    J Pharm Pharmacol; 2011 May; 63(5):603-10. PubMed ID: 21492161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting mutant p53 for efficient cancer therapy.
    Bykov VJN; Eriksson SE; Bianchi J; Wiman KG
    Nat Rev Cancer; 2018 Feb; 18(2):89-102. PubMed ID: 29242642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A balancing act: using small molecules for therapeutic intervention of the p53 pathway in cancer.
    Miller JJ; Gaiddon C; Storr T
    Chem Soc Rev; 2020 Oct; 49(19):6995-7014. PubMed ID: 32869798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Awakening the "guardian of genome": reactivation of mutant p53.
    Binayke A; Mishra S; Suman P; Das S; Chander H
    Cancer Chemother Pharmacol; 2019 Jan; 83(1):1-15. PubMed ID: 30324219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Status quo of p53 in the treatment of tumors.
    Guan YS; He Q; Zou Q
    Anticancer Drugs; 2016 Oct; 27(9):811-8. PubMed ID: 27384591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chaperoning the guardian of the genome. The two-faced role of molecular chaperones in p53 tumor suppressor action.
    Wawrzynow B; Zylicz A; Zylicz M
    Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):161-174. PubMed ID: 29355591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tumor suppressor gene p53 and molecular targeting therapy].
    Takimoto R; Niitsu Y
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1309-13. PubMed ID: 15446548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New therapeutic strategies to treat human cancers expressing mutant p53 proteins.
    Blandino G; Di Agostino S
    J Exp Clin Cancer Res; 2018 Feb; 37(1):30. PubMed ID: 29448954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guardian ancestry: fly p53 and damage-inducible apoptosis.
    Nordstrom W; Abrams JM
    Cell Death Differ; 2000 Nov; 7(11):1035-8. PubMed ID: 11139275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies.
    Harris CC
    J Natl Cancer Inst; 1996 Oct; 88(20):1442-55. PubMed ID: 8841019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 as a therapeutic target: unresolved issues on the road to cancer therapy targeting mutant p53.
    Fojo T
    Drug Resist Updat; 2002 Oct; 5(5):209-16. PubMed ID: 12450786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoring the tumour suppressive function of p53 as a parallel strategy in melanoma therapy.
    Lu M; Miller P; Lu X
    FEBS Lett; 2014 Aug; 588(16):2616-21. PubMed ID: 24844434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 activation by blocking Snail: a novel pharmacological strategy for cancer.
    Lee SH; Park BJ
    Curr Pharm Des; 2011; 17(6):610-7. PubMed ID: 21391911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for manipulating the p53 pathway in the treatment of human cancer.
    Hupp TR; Lane DP; Ball KL
    Biochem J; 2000 Nov; 352 Pt 1(Pt 1):1-17. PubMed ID: 11062053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of p53: effect on prognosis, tumor progression and chemotherapy response.
    Peller S
    Semin Cancer Biol; 1998; 8(5):379-87. PubMed ID: 10101803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 and human cancers.
    Lane DP
    Br Med Bull; 1994 Jul; 50(3):582-99. PubMed ID: 7987642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant p53 reactivation by small molecules makes its way to the clinic.
    Bykov VJ; Wiman KG
    FEBS Lett; 2014 Aug; 588(16):2622-7. PubMed ID: 24768524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour suppressor genes and molecular chaperones.
    Lane DP; Midgley C; Hupp T
    Philos Trans R Soc Lond B Biol Sci; 1993 Mar; 339(1289):369-72; discussion 372-3. PubMed ID: 8493291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.